<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37511572</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11813</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241411813</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Emerging evidence suggests that long non-coding RNA (lncRNA) plays important roles in the regulation of gene expression. We determine the role of using urinary lncRNA as a non-invasive biomarker for lupus nephritis.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We studied three cohorts of lupus nephritis patients (31, 78, and 12 patients, respectively) and controls (6, 7, and 24 subjects, respectively). The urinary sediment levels of specific lncRNA targets were studied using real-time quantitative polymerase chain reactions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The severity of proteinuria inversely correlated with urinary maternally expressed gene 3 (MEG3) (r = -0.423, <i>p</i> = 0.018) and ANRIL levels (r = -0.483, <i>p</i> = 0.008). Urinary MEG3 level also inversely correlated with the SLEDAI score (r = -0.383, <i>p</i> = 0.034). Urinary cancer susceptibility candidate 2 (CASC2) levels were significantly different between histological classes of nephritis (<i>p</i> = 0.026) and patients with pure class V nephritis probably had the highest levels, while urinary metastasis-associated lung carcinoma transcript 1 (MALAT1) level significantly correlated with the histological activity index (r = -0.321, <i>p</i> = 0.004). Urinary taurine-upregulated gene 1 (TUG1) level was significantly lower in pure class V lupus nephritis than primary membranous nephropathy (<i>p</i> = 0.003) and minimal change nephropathy (<i>p</i> = 0.04), and urinary TUG1 level correlated with eGFR in class V lupus nephritis (r = 0.706, <i>p</i> = 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We identified certain urinary lncRNA targets that may help the identification of lupus nephritis and predict the histological class of nephritis. Our findings indicate that urinary lncRNA levels may be developed as biomarkers for lupus nephritis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szeto</LastName><ForeName>Cheuk-Chun</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-8898-8505</Identifier><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences (LiHS), Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>So</LastName><ForeName>Ho</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7113-9390</Identifier><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poon</LastName><ForeName>Peter Yam-Kau</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences (LiHS), Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luk</LastName><ForeName>Cathy Choi-Wan</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences (LiHS), Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Jack Kit-Chung</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0002-9549-9611</Identifier><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fung</LastName><ForeName>Winston Wing-Shing</ForeName><Initials>WW</Initials><Identifier Source="ORCID">0000-0001-7676-7628</Identifier><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Gordon Chun-Kau</ForeName><Initials>GC</Initials><Identifier Source="ORCID">0000-0003-4681-7326</Identifier><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Kai-Ming</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-5310-5197</Identifier><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Fernand Mac-Moune</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Anatomical and Cellular Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Lai-Shan</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Medicine &amp; Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>accounts 6905134, 2410026, and 3133200</GrantID><Agency>The Chinese University of Hong Kong</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015433" MajorTopicYN="Y">Glomerulonephritis, Membranous</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">glomerulonephritis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37511572</ArticleId><ArticleId IdType="pmc">PMC10380660</ArticleId><ArticleId IdType="doi">10.3390/ijms241411813</ArticleId><ArticleId IdType="pii">ijms241411813</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cross J., Jayne D. Diagnosis and treatment of kidney disease. Best Pract. Res. Clin. Rheumatol. 2005;19:785&#x2013;798. doi: 10.1016/j.berh.2005.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2005.05.005</ArticleId><ArticleId IdType="pubmed">16150403</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldman M., Appel G.B. Update on the treatment of lupus nephritis. Kidney Int. 2006;70:1403&#x2013;1412. doi: 10.1038/sj.ki.5001777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5001777</ArticleId><ArticleId IdType="pubmed">16929249</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiehn C., Hajjar Y., Mueller K., Waldherr R., Ho A.D., Andrassy K. Improved clinical outcome of lupus nephritis during the past decade: Importance of early diagnosis and treatment. Ann. Rheum. Dis. 2003;62:435&#x2013;439. doi: 10.1136/ard.62.5.435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.62.5.435</ArticleId><ArticleId IdType="pmc">PMC1754523</ArticleId><ArticleId IdType="pubmed">12695156</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz N., Michaelson J.S., Putterman C. Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis. Ann. N. Y. Acad. Sci. 2007;1109:265&#x2013;274. doi: 10.1196/annals.1398.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1398.032</ArticleId><ArticleId IdType="pubmed">17785315</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada T., Yokoyama H., Tomosugi N., Hisada Y., Ohta S., Naito T., Kobayashi K., Mukaida N., Matsushima K. Detection of urinary interleukin-8 in glomerular diseases. Kidney Int. 1994;46:455&#x2013;460. doi: 10.1038/ki.1994.293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1994.293</ArticleId><ArticleId IdType="pubmed">7967357</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-Deile J., Dannenberg J., Liu P., Lorenzen J., Nystr&#xf6;m J., Thum T., Schiffer M. Identification of cell and disease specific microRNAs in glomerular pathologies. J. Cell. Mol. Med. 2019;23:3927&#x2013;3939. doi: 10.1111/jcmm.14270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14270</ArticleId><ArticleId IdType="pmc">PMC6533525</ArticleId><ArticleId IdType="pubmed">30950172</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaskandan H., Pawluczyk I., Barratt J. Clinical application of microRNAs in glomerular diseases. Nephrol. Dial. Transplant. 2023;38:1375&#x2013;1384. doi: 10.1093/ndt/gfac230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfac230</ArticleId><ArticleId IdType="pubmed">35906877</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos T., Belliere J., Bascands J.L., Neau E., Klein J., Schanstra J.P. miRNAs in urine: A mirror image of kidney disease? Expert Rev. Mol. Diagn. 2015;15:361&#x2013;374. doi: 10.1586/14737159.2015.1009449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737159.2015.1009449</ArticleId><ArticleId IdType="pubmed">25660955</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttman M., Rinn J.L. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482:339&#x2013;346. doi: 10.1038/nature10887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10887</ArticleId><ArticleId IdType="pmc">PMC4197003</ArticleId><ArticleId IdType="pubmed">22337053</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., Chung A.C., Huang X.R., Dong Y., Yu X., Lan H.Y. Identification of novel long noncoding RNAs associated with TGF-&#x3b2;/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am. J. Pathol. 2014;184:409&#x2013;417. doi: 10.1016/j.ajpath.2013.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2013.10.007</ArticleId><ArticleId IdType="pubmed">24262754</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehana N.A., Ghaiad H.R., Hassan M., Elsabagh Y.A., Labib S., Abd-Elmawla M.A. LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Beh&#xe7;et&#x2019;s disease and systemic lupus erythematosus. Life Sci. 2022;309:120965. doi: 10.1016/j.lfs.2022.120965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2022.120965</ArticleId><ArticleId IdType="pubmed">36155183</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S., Ito S., Wada I., Hosokawa N. ER-resident protein 46 (ERp46) triggers the mannose-trimming activity of ER degradation-enhancing &#x3b1;-mannosidase-like protein 3 (EDEM3) J. Biol. Chem. 2018;293:10663&#x2013;10674. doi: 10.1074/jbc.RA118.003129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003129</ArticleId><ArticleId IdType="pmc">PMC6036223</ArticleId><ArticleId IdType="pubmed">29784879</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Elmawla M.A., Fawzy M.W., Rizk S.M., Shaheen A.A. Role of long non-coding RNAs expression (ANRIL, NOS3-AS, and APOA1-AS) in development of atherosclerosis in Egyptian systemic lupus erythematosus patients. Clin. Rheumatol. 2018;37:3319&#x2013;3328. doi: 10.1007/s10067-018-4269-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4269-x</ArticleId><ArticleId IdType="pubmed">30128915</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Liang N., Wang M., Fei Y., Sun J., Li Z., Xu Y., Guo C., Cao Z., Li S., et al. Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus. Oncotarget. 2017;8:77400&#x2013;77406. doi: 10.18632/oncotarget.20490.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.20490</ArticleId><ArticleId IdType="pmc">PMC5652787</ArticleId><ArticleId IdType="pubmed">29100395</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.L., Zhu H.Q., Zhang Y., Zhang C.Y., Jiao J.S., Xing X.Y. LncRNA CASC2 regulates high glucose-induced proliferation, extracellular matrix accumulation and oxidative stress of human mesangial cells via miR-133b/FOXP1 axis. Eur. Rev. Med. Pharmacol. Sci. 2020;24:802&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pubmed">32016985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H.Y., Li D., Wang Y.P., Lu H.X., Sun J., Li H.B. The protection of NF-&#x3ba;B inhibition on kidney injury of systemic lupus erythematosus mice may be correlated with lncRNA TUG1. Kaohsiung J. Med. Sci. 2020;36:354&#x2013;362. doi: 10.1002/kjm2.12183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/kjm2.12183</ArticleId><ArticleId IdType="pubmed">31930775</ArticleId></ArticleIdList></Reference><Reference><Citation>Congrains A., Kamide K., Ohishi M., Rakugi H. ANRIL: Molecular mechanisms and implications in human health. Int. J. Mol. Sci. 2013;14:1278&#x2013;1292. doi: 10.3390/ijms14011278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms14011278</ArticleId><ArticleId IdType="pmc">PMC3565320</ArticleId><ArticleId IdType="pubmed">23306151</ArticleId></ArticleIdList></Reference><Reference><Citation>Potula H.H., Xu Z., Zeumer L., Sang A., Croker B.P., Morel L. Cyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus. J. Immunol. 2012;189:2931&#x2013;2940. doi: 10.4049/jimmunol.1200556.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1200556</ArticleId><ArticleId IdType="pmc">PMC3436953</ArticleId><ArticleId IdType="pubmed">22896639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Wang M., Chen Z., Bhatt K., Oh H.J., Lanting L., Deshpande S., Jia Y., Lai J.Y., O&#x2019;Connor C.L., et al. An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy. Nat. Commun. 2016;7:12864. doi: 10.1038/ncomms12864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12864</ArticleId><ArticleId IdType="pmc">PMC5553130</ArticleId><ArticleId IdType="pubmed">27686049</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu G.Z., Tian W., Fu H.T., Li C.P., Liu B. Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction. Biochem. Biophys. Res. Commun. 2016;471:135&#x2013;141. doi: 10.1016/j.bbrc.2016.01.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.01.164</ArticleId><ArticleId IdType="pubmed">26845358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace C., Smyth D.J., Maisuria-Armer M., Walker N.M., Todd J.A., Clayton D.G. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat. Genet. 2010;42:68&#x2013;71. doi: 10.1038/ng.493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.493</ArticleId><ArticleId IdType="pmc">PMC2820243</ArticleId><ArticleId IdType="pubmed">19966805</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Kan Q.E., Su Y., Man H. Long Non-Coding RNA CASC2 Improves Diabetic Nephropathy by Inhibiting JNK Pathway. Exp. Clin. Endocrinol. Diabetes. 2019;127:533&#x2013;537. doi: 10.1055/a-0629-9958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0629-9958</ArticleId><ArticleId IdType="pubmed">29890555</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Su N., Zhang Y., Wang G. Clinical Significance of Serum lncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients with Type 2 Diabetes. Med. Sci. Monit. 2018;24:6079&#x2013;6084. doi: 10.12659/MSM.909510.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.909510</ArticleId><ArticleId IdType="pmc">PMC6130171</ArticleId><ArticleId IdType="pubmed">30171178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y.M., He Y.S., Wu G.C., Hu Y.Q., Xiang K., Liao T., Yan Y.L., Yang X.K., Shuai Z.W., Wang G.H., et al. Association of MALAT-1 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus. Lupus. 2021;30:1923&#x2013;1930. doi: 10.1177/09612033211040366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211040366</ArticleId><ArticleId IdType="pubmed">34482739</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Zhang Y., Zhong L. LncRNA TUG1 relieves renal mesangial cell injury by modulating the miR-153-3p/Bcl-2 axis in lupus nephritis. Immun. Inflamm. Dis. 2023;11:e811. doi: 10.1002/iid3.811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.811</ArticleId><ArticleId IdType="pmc">PMC10091205</ArticleId><ArticleId IdType="pubmed">37102641</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar-Torres F.J., Medina-Perez M., Melo Z., Mendoza-Cerpa C., Echavarria R. Urinary expression of long non-coding RNA TUG1 in non-diabetic patients with glomerulonephritides. Biomed. Rep. 2021;14:17. doi: 10.3892/br.2020.1393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2020.1393</ArticleId><ArticleId IdType="pmc">PMC7716717</ArticleId><ArticleId IdType="pubmed">33365127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H., Xue Y., Wang P., Wang Z., Li Z., Hu Y., Li Z., Shang X., Liu Y. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144. Oncotarget. 2015;6:19759&#x2013;19779. doi: 10.18632/oncotarget.4331.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.4331</ArticleId><ArticleId IdType="pmc">PMC4637319</ArticleId><ArticleId IdType="pubmed">26078353</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., 3rd, Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009;150:604&#x2013;612. doi: 10.7326/0003-4819-150-9-200905050-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Szeto C.C. Circulating MicroRNAs. Volume 1024. Humana Press; Totowa, NJ, USA: 2013. Methods of microRNA quantification in urinary sediment; pp. 211&#x2013;220. (Methods in Molecular Biology).</Citation><ArticleIdList><ArticleId IdType="pubmed">23719954</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H.Y., Li D., Wang Y.P., Lu H.X., Sun J., Li H.B. Clinical significance of reduced expression of lncRNA TUG1 in the peripheral blood of systemic lupus erythematosus patients. Int. J. Rheum. Dis. 2020;23:428&#x2013;434. doi: 10.1111/1756-185X.13786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13786</ArticleId><ArticleId IdType="pubmed">31944629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari S., Watson N., Long E., Sharpe S., Zhong W., Xu S.Z., Atkin S.L. Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney. J. Histochem. Cytochem. 2008;56:733&#x2013;743. doi: 10.1369/jhc.2008.950998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/jhc.2008.950998</ArticleId><ArticleId IdType="pmc">PMC2443611</ArticleId><ArticleId IdType="pubmed">18443363</ArticleId></ArticleIdList></Reference><Reference><Citation>Weening J.J., D&#x2019;Agati V.D., Schwartz M.M., Seshan S.V., Alpers C.E., Appel G.B., Balow J.E., Bruijn J.A., Cook T., Ferrario F., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521&#x2013;530. doi: 10.1111/j.1523-1755.2004.00443.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00443.x</ArticleId><ArticleId IdType="pubmed">14717922</ArticleId></ArticleIdList></Reference><Reference><Citation>Grande J.P., Balow J.E. Renal biopsy in lupus nephritis. Lupus. 1998;7:611&#x2013;617. doi: 10.1191/096120398678920730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120398678920730</ArticleId><ArticleId IdType="pubmed">9884098</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneval P., Bari&#xe9;ty J., B&#xe9;lair M.F., Mandet C., Heudes D., Nicoletti A. Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice. Nephrol. Dial. Transplant. 2002;17:2099&#x2013;2107. doi: 10.1093/ndt/17.12.2099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/17.12.2099</ArticleId><ArticleId IdType="pubmed">12454219</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO (Kidney Disease Improving Global Outcomes) Clinical Practice Guideline for Glomerulonephritis. Kidney Int. Suppl. 2012;2:1&#x2013;274.</Citation></Reference><Reference><Citation>Chan R.W., Szeto C.C. Advances in the clinical laboratory assessment of urinary sediment. Clin. Chim. Acta. 2004;340:67&#x2013;78. doi: 10.1016/j.cccn.2003.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cccn.2003.11.006</ArticleId><ArticleId IdType="pubmed">14734197</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan R.W., Lai F.M., Li E.K., Tam L.S., Chung K.Y., Chow K.M., Li P.K., Szeto C.C. Urinary mononuclear cell and disease activity of systemic lupus erythematosus. Lupus. 2006;15:262&#x2013;267. doi: 10.1191/0961203306lu2287oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203306lu2287oa</ArticleId><ArticleId IdType="pubmed">16761499</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattick J.S., Amaral P.P., Carninci P., Carpenter S., Chang H.Y., Chen L.L., Chen R., Dean C., Dinger M.E., Fitzgerald K.A., et al. Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 2023;24:430&#x2013;447. doi: 10.1038/s41580-022-00566-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-022-00566-8</ArticleId><ArticleId IdType="pmc">PMC10213152</ArticleId><ArticleId IdType="pubmed">36596869</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>